Cannabis Law Report

DECEMBER 23, 2021

In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals. billion by 2025. This report has been compiled to assist interested parties in understanding the market for the medical use of cannabinoids and where it may be heading.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

JULY 15, 2022

Last week, federal Health Minister Greg Hunt announced changes to regulations that would allow for medicinal cannabis exports, capitalising on what the Government estimated would be a $70 billion industry by 2025. So without going on to the advertising side of things, very important to have your clinical trials obviously based on products.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

MAY 19, 2019

In Nigeria, it is often referred to as ‘Indian hemp’, in the country, Cannabis Sativa, which has enjoyed use as fibre, seed and seed oils, medicinal purposes, and as a recreational drug traces its origin to Central and South Asia. billion dollars by 2025. Underlining supplied for emphasis). Health Benefits of Cannabis.

Legalization 45

Legalization Seed-To-Sale Marijuana Decriminalization 45

Cannabis Law Report

OCTOBER 17, 2019

Hemp’s fibers, seeds, and flowers can be used to make paper, textiles, construction materials, rope, hemp seeds and hemp seed oils, and much more. CBD can be extracted from the flowers of plants classified as industrial hemp as well as those with higher THC content. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40